ICG strives to provide exceptional results for their clients by creating mock panels with the highest level of expertise and with detail oriented management throughout the entire process.

ICG brings together a panel of experts that provide necessary feedback to assure that the company presenters are well prepared for any questions that may arise during the actual advisory committee meeting. In most circumstances, the mock panelists include:

• Individuals who have been FDA division directors, FDA Deputy Directors, FDA reviewers or held other senior positions at the agency
• Statistician(s) knowledgeable in the area of the presentation
• Individuals with clinical and scientific experience in the therapeutic area of the product
• Individuals who bring additional relevant perspectives in areas where the FDA may include a voting consultant on the advisory committee panel (e.g. pharmacologist focusing on drug interactions)
• Former members of various FDA advisory committees with extensive experience in how advisory committees function and interact